Although its upregulation is closely associated with tumor progression, metastasis and chemotherapy resistance, its mechanistic basis reveals environment-dependent regulatory mechanisms; therefore, RRBP1 is a highly promising therapeutic target across cancer types. This evidence concerns the gene RRBP1 and neoplasm.